Company

Origin Biologics is a regenerative medicine company that develops and delivers innovative allograft and regenerative clinical solutions designed to support and maximize the body’s regenerative and healing potential. Our ultimate goal is to improve patient outcomes and quality of life while honoring and valuing the gift of donation.

Origin Biologics is relatively new in the US market and draws upon our sister company, Australian Biotechnologies’ extensive 21 year history of producing life enhancing allografts to over 70,000 patients throughout Australia. Origin has partnered with Nevada Donor Network to provide differentiated bone grafting solutions to the surgical marketplace. Our strategy is aligned to recognize the shift in the healthcare marketplace towards “PURE” bone grafting solutions without carriers. In addition, our Dry State technologies maximize the long-term viability of truly valuable donor tissue, thereby supporting our goal of honoring the gift of donation.

At Origin Biologics, we are strategically focused on providing clinically superior products backed by long- term clinical evidence and delivered to our customers in a cost-effective manner.

Osteovance® Processing Technology Facilitates, Orchestrates and Promotes Bone Healing.

Proprietary fiber geometry can be tailored to suit various specialty applications, such as spinal, orthopedic, foot and ankle.

Characteristics

• Superior hydration characteristics vs other fibers
  • Very quick hydration minimizing OR preparation time
• Versatile handling characteristics vs other fibers
  • Easy to pack and place in difficult defects
• Unique expansion capabilities
  • Maximizes contact with bony areas to enhance fusion potential

Origin Biologics Highlights

• Management team boasts over
  100 years of combined orthobiologic industry experience that includes basic research, product development, quality, manufacturing, business development and donor procurement relationships
• Located within 15 minutes of the seventh busiest airport in the United States (McCarran International – LAS)
• 22,000ft2 manufacturing and distribution center
  • Nine modular cleanrooms Five, ISO Class 5 manufacturing suites › Two, ISO Class 6 manufacturing suites › Two, ISO Class 7 support suites
  • Capacity to meet and exceed required demand
  • Vertically integrated central supply and distribution center

• Regulatory Compliance for the storage, manufacturing and distribution of HCT/P’s and Medical Device Implants:
  • Food and Drug Administration (FDA)
  • All relevant State registrations as appropriate
  • ISO 13485: Quality System for Medical Devices
  • American Association of Tissue Banks (AATB)